Abstract:Purpose: Penicillins are a potent antibiotic in managing odontogenic infections, but 10% of the population is labelled as allergic to these drugs. This has limited their use and resulted in increased utilization of health care resources as well as complications associated with alternative antibiotics. The purpose of the study was to measure the association between patients labeled as penicillin allergic and treatment outcomes in a sample of patients treated for complicated odontogenic infections. Additionally, we sought to investigate antibiotic resistance patterns in these patients. Materials and methods: A retrospective cohort study was performed at the Michigan Medicine health care system to include patients who were treated for complicated odontogenic infections by oral and maxillofacial surgery between 2016 and 2020. Complicated odontogenic infection was defined as any odontogenic infection requiring admission and surgical management in the operating room. The primary predictor variable was the penicillin allergy label, which was determined by chart review and not confirmed with formal testing. Outcomes were measures of disease severity. The primary outcome variable was hospital length of stay. Secondary outcome variables were ICU admission (yes/no), repeat computed tomography scan(s), repeat surgery (yes/no), and re-admission (yes/no). Co-variates included were age, sex (male/female), tobacco use status, diabetes, immunocompromised state, number of spaces involved, white blood cell count upon admission and insurance status. For our secondary aim, the primary predictor variable was again penicillin allergy and outcome variable was antibiotic resistance as determined by wound culture results following surgical intervention. Negative binomial regression and logistic regression analyses were performed. P < .05 was considered significant. Results: A total of 150 patients met the inclusion criteria and of those 17.3% reported as penicillin allergic. Patients labelled as penicillin allergic did not differ significantly from patients without penicillin allergy label in terms of treatment outcomes. Age, diabetes, and immunosuppression were associated with an increased length of stay. Patients labelled as penicillin allergic were at significantly higher risk for antibiotic resistance (relative risk = 2.34; 95% confidence interval, 1.66 to 3.32; P < .001), specifically clindamycin resistance (relative risk = 3.17; 95% confidence interval, 1.93 to 5.18; P < .001). Conclusions: Penicillin allergy was significantly associated with clindamycin resistance. There were similar outcomes amongst patients with and without a penicillin allergy label despite antibiotic differences. Delabeling efforts for patients with a reported penicillin allergy must be considered and local nomograms for antibiotic selection should be used by providers when seeking alternative antibiotics.

Documented penicillin allergy and beta-lactam antibiotic use in Massachusetts long-term care facilities: opportunities for penicillin allergy delabeling

Antibiotic Allergy Prevalence and Documentation Quality in Massachusetts Long-Term Care Facilities: A Cross-Sectional Survey

Introduction of a penicillin allergy de-labelling program with direct oral challenge and its effects on utilization of beta-lactam antimicrobials: a multicenter retrospective parallel cohort study

The appropriateness of penicillin allergy de-labelling by non-allergist clinical ward teams

Promoting penicillin allergy de‐labeling for children attending a hematology clinic

Rising to the Challenge: An ID Provider–Led Initiative to Address Penicillin Allergy Labels at a Large Veterans Affairs Medical Center

Retrospective study on penicillin allergy delabeling and evaluation of an antibiotic allergy assessment tool

Penicillin allergy delabeling has a significant impact on subsequent antibiotic use in primary care

[Reevaluation of penicillin allergy labeling, appropriate use of β-lactam antibiotics, and multidrug resistance]

Patient Perceptions of Penicillin Allergy Testing in a Public Health System

The challenge of de‐labeling penicillin allergy

Removing penicillin allergy label in a hospitalized adolescent with a remote penicillin and recent cephalosporin allergy

Not a Benign (Mis)Label: Penicillin Allergy Education for the Nonallergist

Documentation of penicillin adverse drug reactions in electronic health records: inconsistent use of allergy and intolerance labels

Proactive management of penicillin and other antibiotic allergies

567. The Quality & Management of Penicillin Allergy Labels in a Pediatric Birth Cohort

Effectiveness and feasibility of a penicillin allergy delabeling program in the postacute inpatient rehabilitation setting

Penicillin and Beta-Lactam Allergy: Epidemiology and Diagnosis

Does thePenicillin Allergy Label Affect Outcomes of Complicated Odontogenic Infections?

Beta‐lactam allergy risk stratification in a maternity population in Australia: Scope for allergy de‐labelling

Adult penicillin allergy programmes in Australian hospitals: a practical guide from the National Antibiotic Allergy Network